CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,230
edits
No edit summary Tag: Manual revert |
No edit summary |
||
| Line 5: | Line 5: | ||
|TopOrganization=National Institutes of Health | |TopOrganization=National Institutes of Health | ||
|CreationLegislation=National Cancer Institute initiative | |CreationLegislation=National Cancer Institute initiative | ||
|Purpose= | |Purpose=Barrett's Esophagus Translational Research Network advanced study of Barrett’s esophagus and its cancer link, aiming to improve detection, prevention, and risk strategies. | ||
|Website=https://prevention.cancer.gov/research-groups/barretts-esophagus-translational-research-network-betrnet | |Website=https://prevention.cancer.gov/research-groups/barretts-esophagus-translational-research-network-betrnet | ||
|ProgramStart=2011 | |ProgramStart=2011 | ||
|InitialFunding=$5.4 million (initial grant) | |InitialFunding=$5.4 million (initial grant) | ||
|Duration=2011-2022 | |Duration=2011-2022 | ||
|Historic= | |Historic=Yes | ||
}} | }} | ||
'''Barrett's Esophagus Translational Research Network''' (BETRNet) was a National Institutes of Health initiative that advanced understanding of Barrett’s esophagus (BE) and esophageal adenocarcinoma (EA) by fostering multi-institutional, transdisciplinary research, involving three research centers and a coordinating center to accelerate the translation of findings into clinical practice. Launched in 2011 by the National Cancer Institute (NCI), it centralized efforts across institutions like the University of Michigan and Case Western Reserve University, generating over 100 publications and a biorepository of BE/EA biospecimens, concluding its collaborative activities by 2022 after enhancing risk prediction models and prevention strategies. | '''Barrett's Esophagus Translational Research Network''' (BETRNet) was a National Institutes of Health initiative that advanced understanding of Barrett’s esophagus (BE) and esophageal adenocarcinoma (EA) by fostering multi-institutional, transdisciplinary research, involving three research centers and a coordinating center to accelerate the translation of findings into clinical practice. Launched in 2011 by the National Cancer Institute (NCI), it centralized efforts across institutions like the University of Michigan and Case Western Reserve University, generating over 100 publications and a biorepository of BE/EA biospecimens, concluding its collaborative activities by 2022 after enhancing risk prediction models and prevention strategies. | ||
edits